复方薤白胶囊对野百合碱诱导大鼠肺动脉高压的抑制作用

奚肇庆; 姜静; 孙菊光; 朱萱萱; 洪建军; 徐艳; 甘永梅; 丰广魁

doi:10.13288/j.11-2166/r.2006.10.038

您当前的位置：

首页 >

文章列表页 >

复方薤白胶囊对野百合碱诱导大鼠肺动脉高压的抑制作用

更新时间：2021-11-17

- 复方薤白胶囊对野百合碱诱导大鼠肺动脉高压的抑制作用
- Inhibitory Effect of Compound Xiebai Capsules on Pulmonary Hypertension Induced by Monocrotaline in Rats
- 中医杂志 2006年第10期页码：781-783
- 作者机构：
  
  1. 江苏省中医院急症临床研究室
  2. 南京中医药大学急症临床研究室
- 作者简介：
- 基金信息：
  
  江苏省中医药局资助课题（H-034）
- DOI：10.13288/j.11-2166/r.2006.10.038
  中图分类号： R285
- 纸质出版：2006
- 稿件说明：
移动端阅览
[1]奚肇庆,姜静,孙菊光,朱萱萱,洪建军,徐艳,甘永梅,丰广魁.复方薤白胶囊对野百合碱诱导大鼠肺动脉高压的抑制作用[J].中医杂志,2006(10):781-783.

Xi Zhaoqing1, Jiang Jing2, Sun Juguang2, et al. Inhibitory Effect of Compound Xiebai Capsules on Pulmonary Hypertension Induced by Monocrotaline in Rats[J]. Journal of Traditional Chinese Medicine2006, (10): 781-783.
[1]奚肇庆,姜静,孙菊光,朱萱萱,洪建军,徐艳,甘永梅,丰广魁.复方薤白胶囊对野百合碱诱导大鼠肺动脉高压的抑制作用[J].中医杂志,2006(10):781-783. DOI： 10.13288/j.11-2166/r.2006.10.038.

Xi Zhaoqing1, Jiang Jing2, Sun Juguang2, et al. Inhibitory Effect of Compound Xiebai Capsules on Pulmonary Hypertension Induced by Monocrotaline in Rats[J]. Journal of Traditional Chinese Medicine2006, (10): 781-783. DOI： 10.13288/j.11-2166/r.2006.10.038.

摘要

目的:探讨复方薤白胶囊对野百合碱诱导肺动脉高压大鼠模型内皮素（ET）和白介素-6（IL-6）的影响。方法:70只SD大鼠随机分为正常对照组、模型组、地塞米松组、桂龙咳喘宁组、卡托普利组和复方薤白胶囊大、小剂量组。腹腔注射野百合碱造模后

测定各组大鼠平均肺动脉压和平均右心室压

放射免疫法测定血浆中ET和IL-6含量。结果:复方薤白胶囊大、小剂量组平均肺动脉压与模型组及卡托普利组比较

差异均有显著性意义（P<0.05或P<0.01）。复方薤白胶囊大剂量组ET含量明显低于模型组（P<0.05）。结论:复方薤白胶囊能有效降低模型大鼠肺动脉高压

其作用原理可能与降低血浆中ET含量有关。

Abstract

Objective:To study the effects of Compound Xiebai Capsules on endothelin（ET） and interlukin-6（IL-6） levels in the pulmonary hypertension model rat induced by Monocrotaline.Methods:Seventy SD rats were randomly divided into normal control group

model group

dexamethasone group

Guilong Kechuanning group

Captopril group

large dose Compound Xiebai Capsules group and small dose Compound Xiebai Capsules group.The pulmonary hypertension rat model was made by intraperitoneal injection of Monocrotaline

and mean pulmonary arterial pressure and right ventricular pressure were determined.Radioimmunoassay was used to determin level of ET and IL-6.Results:There were significant differences in pulmonary arterial pressure in large dose and small dose of Compound Xiebai Capsule group as compared with the model group and the Captopril group （P<0.05 or P<0.01）.ET level in the large dose Compound Xiebai Capsules group was significantly lower than that in the model group（P<0.05）.Conclusion:Compound Xiebai Capsules can effectively decrease pulmonary hypertension in model rats

which is possibly related with decrease of plasma ET level.

关键词

Keywords

references

查看原文

浏览量

199

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

李果烈从“升清降浊”辨治直立性低血压经验

通便汤对慢传输型便秘模型大鼠结肠组织VAPB-PTPIP51复合物及Cajal间质细胞自噬的影响

调气定神法刍议

真实世界研究视角下功能性消化不良-肠易激综合征共病随机对照试验的现状分析及对策建议

从“内风暗旋”辨治小细胞肺癌